Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
Prevalence and Genotype Distribution of Human Papillomavirus Infection Among 12 076 Iranian Women Publisher Pubmed



Bitarafan F1 ; Hekmat MR1 ; Khodaeian M1 ; Razmara E2 ; Ashrafganjoei T3 ; Modares Gilani M4 ; Mohit M5 ; Aminimoghaddam S6 ; Cheraghi F7 ; Khalesi R1 ; Rajabzadeh P1 ; Sarmadi S8 ; Garshasbi M2
Authors
Show Affiliations
Authors Affiliations
  1. 1. Department of Medical Genetics, DeNA Laboratory, Tehran, Iran
  2. 2. Department of Medical Genetics, Faculty of Medical Sciences, Tarbiat Modares University, Teheran, Iran
  3. 3. Imam Hosein Hospital, Shahid Beheshti University of Medical Sciences, Tehran, Iran
  4. 4. Tehran University of Medical Sciences, Tehran, Iran
  5. 5. Department of Obstetrics and Gynecology, Faculty of Medicine, Tehran Medical Branch, Islamic Azad University, Tehran, Iran
  6. 6. Iran University of Medical Sciences, Tehran, Iran
  7. 7. Erfan Hospital, Tehran, Iran
  8. 8. Department of Pathology, School of Medicine, Tehran University of Medical Sciences, Tehran, Iran

Source: International Journal of Infectious Diseases Published:2021


Abstract

Introduction: Human papillomavirus (HPV) infection is one of the major health concerns of women in developing countries. This study gives an insight into the prevalence and genotype distribution of HPV infection and compares it with Pap smear results among Iranian women. Methods: In this study, 12 076 Iranian women underwent routine examination from November 2016 to November 2018 using HPV Direct Flow CHIP System for HPV DNA typing. Cytology was undertaken for 5138 samples. Results: Overall HPV prevalence was calculated at 38.68%. The most frequent HPV types were HPV 6, 16, 11, 62/81, 52 and 54. The most high-risk HPV (HR-HPV) types were HPV 16, 52, 18, 39, 31 and 51. These 2 groups represent approximately half of all HPV types detected, 47% and 55%, respectively. Among individuals who underwent cytological tests, 135 individuals (2.63%) were cytologically positive. In this group, 81 individuals (60%) were HPV positive, 62 (76%) of whom were HR-HPV positive, most frequently with HPV 16 (34%). Conclusion: This study highlights the urgent need for public education and early diagnosis using HPV screening tests to prevent cervical cancer. © 2021 The Authors
Experts (# of related papers)